- Home
- TNGX vs MIN Comparison
TNGX vs MIN Comparison
Compare TNGX & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | MIN |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 302.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TNGX | MIN |
|---|---|---|
| Price | $9.32 | $2.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 331.0K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.31% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | ★ $66,501,000.00 | N/A |
| Revenue This Year | $53.01 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.38 |
| Revenue Growth | ★ 53.29 | N/A |
| 52 Week Low | $1.03 | $2.52 |
| 52 Week High | $11.20 | $2.88 |
Technical Indicators
Market Signals| Indicator | TNGX | MIN |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 41.71 |
| Support Level | $8.89 | $2.60 |
| Resistance Level | $10.22 | $2.67 |
| Average True Range (ATR) | 0.63 | 0.03 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 20.91 | 28.57 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.